Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
36.67
+0.04 (0.11%)
May 4, 2026, 1:02 PM EDT - Market open
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $6.27 billion as of May 4, 2026. Its market cap has increased by 1,227.52% in one year.
Market Cap
6.27B
Enterprise Value
5.62B
1-Year Change
1,227.52%
Ranking
Category
Stock Price
$36.67
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $6.27B, an increase of 4,942.14%. That is a compound annual growth rate of 96.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 6.26B | 15.83% |
| Dec 31, 2025 | 5.40B | 527.16% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 6.59B |
| Protagonist Therapeutics | 6.28B |
| Centessa Pharmaceuticals | 6.12B |
| Terns Pharmaceuticals | 6.11B |
| Belite Bio | 6.09B |
| Celcuity | 6.07B |
| Apogee Therapeutics | 6.03B |
| Spyre Therapeutics | 5.99B |